Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso, Loris Riccardo; Petito, Valentina; Graziani, Cristina; Schiavoni, Elisa; Paroni Sterbini, Francesco; Poscia, Andrea; Gaetani, Eleonora; Franceschi, Francesco; Cammarota, Giovanni; Sanguinetti, Maurizio; Masucci, Luca; Scaldaferri, Franco; Gasbarrini, Antonio.
; 36(1): 56-65, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28683448
Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Gut microbiota as potential orchestrators of irritable bowel syndrome.
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.
Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management.
Systematic review and comparison of national and international guidelines on diverticular disease.
Assessment of Environmental Enteric Dysfunction in the SHINE Trial: Methods and Challenges.
C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
Diverticular Disease: The Old, the New, and the Ever-Changing View.
Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.